Marwood Group + ACHP Webinar 9/12 : Navigating Medicare Advantage Risk Adjustment
August 23, 2023
Experts from the Marwood Group and the Alliance of Community Health Plans are hosting an exclusive webinar event on September 12th focused on navigating MA risk adjustment. The interactive discussion will focus on the risk adjustment program history, outlook for V28 changes and strategies for positioning your organization in 2024 and beyond. Click below for more information and registration link.
Opportunities In Fertility Services – Regulatory Considerations For Surrogacy Agencies
August 23, 2023
In our second of a two-part series exploring opportunities in fertility services, Marwood’s Scott Silberberg, Nayab Mahmood, and Colleen Burke address the growing demand and consumer-sensitive market for surrogacy services in the U.S., the supportive political and legal landscape American surrogacy agencies enjoy compared to providers in international markets, and the increasing numbers of large companies and employers adopting surrogacy as part of their family-building benefit.
Artificial Intelligence In Healthcare Worker Sourcing And Staffing
June 28, 2023
Marwood’s Mark Slomiany PhD MBA MPA and Rahul Sastry explore the evolving market and regulatory landscape of AI in healthcare worker recruitment and staffing
Advances In Weight Loss Drug Development And The Impact On Provider Services
June 14, 2023
Marwood’s Mark Slomiany PhD MBA MPA presents recent advances in prescription weight management, the state of the pipeline, and impacts on specialized practices, as well as ancillary services.
Opportunities In Fertility Services – The Importance Of State-Level Analysis
May 24, 2023
Marwood’s Scott Silberberg MA and Mark Slomiany PhD MBA MPA address state regulatory and commercial payor tailwinds in the fertility space; the first of a two-part series
Opportunities For Growth And Consolidation In The Cosmetic Surgery & Medspa Market
May 2, 2023
Marwood’s Mark Slomiany, Deborah Freier and Scott Silberberg delineate opportunities in the cosmetic surgery & medspa market, providing perspective on market and regulatory diligence crucial in evaluating individual targets and platforms in the sector.
Diagnostic Radiopharmacy: Overview And Market Access Considerations
April 5, 2023
Mark Slomiany presents a decision analysis structure for evaluating pass through considerations among novel radiopharmaceutical tracers for PET and SPECT.